Twenty two patients from
lower occurrence of skeletal deformities. The peripheral and central neurophysiological findings, sural nerve biopsy, and the neuroradiological picture did not allow the differentiation between "late onset" and "typical" Friedreich's disease. Duration of disease from onset to becoming confined to a wheelchair was five years longer in late onset patients. Sixteen patients and 25 healthy members from eight families were typed with the chromosome 9 markers MLS1, MS, and GS4 tightly linked to the FRDA locus. All families showed positive lod scores with a combined value of 5*17 at a recombination fraction of 0 = 0 00. It is concluded that "late onset" Friedreich's disease is milder than the "typical" form and that it maps to the same locus on chromosome 9.
(7 Neurol Neurosurg Psychiatry 1994;57:977-979) Friedreich 's disease is an autosomal recessive disorder that represents the most common form of hereditary ataxia in large series.' Age of onset was at about the time of puberty in the nine patients originally described by Friedreich, but a later onset has sometimes been described. For instance, Potts3 reported an onset between ages 27 and 36 years in three siblings. Geoffroy et al, 4 in an effort to define strict diagnostic criteria for Friedreich's disease, established that "true" Friedreich's disease must always begin before the end of puberty and at the latest before the age of 20. Harding' considered the onset before 25 years of age an essential diagnostic criterion.
In 1989 we reported nine patients with Friedreich's disease phenotype but with age of onset ranging from 21 to 29. We suggested that "late onset" Friedreich's disease may be a distinct genetic entity or may result from modifying secondary genes in some families. 5 Chamberlain The following microsatellite polymorphisms were studied for linkage analysis:GS4 (D9S111), MCT112/MS (D9S15), MLS1 (D9S202).>" For the DNA analysis a blood sample was taken in 50 mM EDTA. Genomic DNAs were prepared according to described procedures." The polymerase chain reaction was used to detect microsatellite polymorphisms. DNA from each subject was amplified in 50 ul of polymerase chain reaction buffer (10 mM Tris HC1 pH 8 
